KEROS THERAPEUTICS INC (KROS) Forecast, Price Target & Analyst Ratings

NASDAQ:KROS • US4923271013

Current stock price

10.95 USD
-0.39 (-3.44%)
At close:
10.95 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KEROS THERAPEUTICS INC (KROS).

Forecast Snapshot

Consensus Price Target

Price Target
$24.19
+ 120.90% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$1.00
Revenue Estimate
72.859K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$24.19
Upside
+ 120.90%
From current price of $10.95 to mean target of $24.19, Based on 15 analyst forecasts
Low
$16.16
Median
$23.46
High
$36.75

Price Target Revisions

1 Month
0.91%
3 Months
1.45%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for KROS. The average price target is 24.19 USD. This implies a price increase of 120.9% is expected in the next year compared to the current price of 10.95.
The average price target has been revised upward by 1.45% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

KROS Current Analyst RatingKROS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

KROS Historical Analyst RatingsKROS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Analyst Ratings Consensus

ChartMill Buy Consensus
78.67%
KROS was analyzed by 15 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about KROS.
In the previous month the buy percentage consensus was at a similar level.
KROS was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-05Wells FargoMaintains Overweight -> Overweight
2025-11-28B of A SecuritiesMaintains Neutral -> Neutral
2025-11-12OppenheimerReiterate Outperform -> Outperform
2025-11-11Wells FargoMaintains Overweight -> Overweight
2025-11-06WedbushMaintains Neutral -> Neutral
2025-08-08HC Wainwright & Co.Maintains Buy -> Buy
2025-06-10B of A SecuritiesDowngrade Buy -> Neutral
2025-05-30WedbushReiterate Neutral -> Neutral
2025-05-12ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-05-08HC Wainwright & Co.Maintains Buy -> Buy
2025-04-09Truist SecuritiesMaintains Buy -> Buy
2025-04-01WedbushReiterate Neutral -> Neutral
2025-04-01HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-27Wells FargoMaintains Overweight -> Overweight
2025-02-27HC Wainwright & Co.Maintains Buy -> Buy
2025-01-21Cantor FitzgeraldDowngrade Overweight -> Neutral
2025-01-17GuggenheimReiterate Neutral -> Neutral
2025-01-17WedbushDowngrade Outperform -> Neutral
2025-01-17Piper SandlerMaintains Overweight -> Overweight
2025-01-16ScotiaBankMaintains Sector Outperform -> Sector Outperform
2025-01-16OppenheimerMaintains Outperform -> Outperform
2024-12-23Truist SecuritiesMaintains Buy -> Buy
2024-12-16GuggenheimDowngrade Buy -> Neutral
2024-12-16OppenheimerMaintains Outperform -> Outperform
2024-12-13ScotiaBankMaintains Sector Outperform -> Sector Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$1.00
Revenue Estimate
72.859K
Revenue Q2Q
-99.97%
EPS Q2Q
-127.69%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
-85.51%
Revenue (3 Months)
-85.51%
EPS (1 Month)
-35.01%
EPS (3 Months)
-35.01%

Next Earnings Summary

KROS is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -1 USD and the consensus revenue estimate is 72.86K USD.
The next earnings revenue estimate has been revised downward by 85.51% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
KROS revenue by date.KROS revenue by date.
151K3.55M
2,250.99%		244.061M
6,774.96%		9.812M
-95.98%		3.006M
-69.36%		62.921M
1,993.18%		86.197M
36.99%		123.74M
43.55%		238.78M
92.97%		364.88M
52.81%		358.93M
-1.63%
EBITDA
YoY % growth
KROS ebitda by date.KROS ebitda by date.
-169.126M
-48.20%		-209.604M
-23.93%		72.078M
134.39%		-80.988M
-212.36%		-83.232M
-2.77%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
KROS ebit by date.KROS ebit by date.
-169.941M
-48.05%		-210.833M
-24.06%		70.569M
133.47%		-173.221M
-345.46%		-181.729M
-4.91%		-169.58M
6.69%		-218.938M
-29.11%		-245.037M
-11.92%		-279.867M
-14.21%		-261.609M
6.52%		107.9M
141.24%
Operating Margin
KROS operating margin by date.KROS operating margin by date.
-112,543.71%-5,938.96%28.91%-1,765.40%-6,045.54%-269.51%-254.00%-198.03%-117.21%-71.70%30.06%
EPS
YoY % growth
KROS eps by date.KROS eps by date.
-5.20
-25.30%		-5.01
3.65%		1.82
136.33%		-3.62
-299.03%		-4.02
-10.91%		-2.66
33.78%		-2.77
-3.99%		-2.45
11.52%		-0.70
71.25%		0.60
185.03%		1.56
160.22%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-1.00
-127.69%		-0.77
-1.46%		-0.38
-110.80%		-0.94
-9.71%		-0.77
23.69%		-0.77
0.79%		-0.66
-74.73%		-0.58
38.38%
Revenue
Q2Q % growth		72.859K
-99.97%		507.96K
-97.20%		641.325K
-95.50%		647.7K
68.23%		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-29.274M
-119.21%		-30.631M
21.67%		29.009M
303.22%		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-35.279M
-123.20%		-38.478M
3.36%		-26.071M
-69.47%		-36.588M
-25.00%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

KROS Yearly Revenue VS EstimatesKROS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
KROS Yearly EPS VS EstimatesKROS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 -4 -6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-51.28%
EPS Next 5 Year
-27.32%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-36.73%
Revenue Next 5 Year
-13.01%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

KEROS THERAPEUTICS INC / KROS Forecast FAQ

What is the price target for KROS stock?

15 analysts have analysed KROS and the average price target is 24.19 USD. This implies a price increase of 120.9% is expected in the next year compared to the current price of 10.95.

What is the next earnings date for KROS stock?

KEROS THERAPEUTICS INC (KROS) will report earnings on 2026-05-04, before the market open.

What are the consensus estimates for KROS stock next earnings?

The consensus EPS estimate for the next earnings of KEROS THERAPEUTICS INC (KROS) is -1 USD and the consensus revenue estimate is 72.86K USD.

Can you provide the expected long term growth rate for KEROS THERAPEUTICS INC stock?

The expected long term growth rate for KEROS THERAPEUTICS INC (KROS) is -36.73%.